+1 915 229 3004 (U.S.) | 
+44 7452 242832 (U.K.)
+1 915 229 3004 (U.S.) | +44 7452 242832 (U.K.)
The global diabetes drug market, estimated at USD 61.88 billion in 2022, is anticipated to reach around USD 118.01 billion by 2032, growing at a Compound Annual Growth Rate (CAGR) of 6.68% from 2023 to 2032. Diabetes, a chronic metabolic disease causing elevated blood glucose levels, affects 62 million people in the Americas, primarily in low- and middle-income countries, and is responsible for 284,049 deaths annually.
The rise in the diabetic population, technological advancements, increased sales of novel medicines, and growing adoption rates in developing regions are key drivers of the diabetes drug market. Factors such as increased obesity, sedentary lifestyles, and unhealthy diets contribute to the growing incidence of diabetes, fueling industry growth.
North America is expected to dominate the market share during the forecast period.
The insulin segment is projected to exhibit the fastest CAGR from 2023 to 2032.
Type 2 diabetes is anticipated to dominate the global market during the forecast period.
The oral segment accounted for over 46.1% of revenue share in 2022.
Hospital pharmacies captured more than 54.1% of revenue share in 2022.
The COVID-19 crisis has adversely affected the world economy and the diabetes drug supply chain. Many countries reported shortages of diabetic drugs at the retail level, coinciding with a general decrease in consumption due to pandemic-related restrictions.
Excessive sugar consumption leading to diabetes incidents.
Advancements in diabetes diagnosis devices.
Increase in R&D activities and market approvals for novel treatments.
Stringent regulatory environment and time-consuming approval processes.
Technological advancements in diabetes treatment.
Introduction of high-end insulin pumps and pens.
The insulin segment dominated the market in 2022, driven by demand from the Type-1 diabetes population.
Type 2 diabetes led the market in 2022, with global sales reaching USD 67.71 billion.
Oral anti-diabetic drugs are expected to dominate the North America market.
Hospital pharmacies dominated the market, with online pharmacies showing promise.
North America, particularly the United States, holds the largest market share, with a CAGR of around 3% during the forecast period. The region witnesses a continuous rise in diabetes cases, driving the development of new drugs.
Approval of Mounjaro (tirzepatide) injection for blood sugar control in adults with type 2 diabetes.
Insulin glargine and liraglutide outperforming other medications for blood glucose control.
Approval of Semglee, the first interchangeable biosimilar insulin product.
Major players include Novo Nordisk, Sanofi, Merck & Co, Eli Lilly, AstraZeneca, Takeda Pharmaceuticals, Boehringer Ingelheim, Novartis, Johnson & Johnson, and Bayers AG.
Segments covered include drug class (Insulin, DPP-4 Inhibitors, GLP-1 Receptor Agonists, SGLT2 Inhibitors), diabetes type (Type 1, Type 2), route of administration (Oral, Subcutaneous, Intravenous), distribution channel (Online pharmacies, Hospital Pharmacies, Retail pharmacies), and geography (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa).
The global diabetes drug market, estimated at USD 61.88 billion in 2022, is anticipated to reach around USD 118.01 billion by 2032.
The global market is projected to grow at a CAGR of 6.68% during the forecast period, 2023-2032.
Research on the market is done by industry professionals who provide personalized insights on the industry structure, market segmentation, Type assessment, competitive landscape (CL), along with penetration, and emerging trends. In addition to years of professional experience in their various fields and sectors, their analysis is largely based on primary interview (60%) and secondary research (40%) as well as years of professional experience. In addition, our researchers forecast the market's direction over the following seven years by examining past trends and the market's current position. Additionally, various trends of segments and categories that are geographically portrayed are studied and estimated using primary and secondary research.
The key level executives (VP, CEO, Marketing Directors, and Business Development Managers) of the major industry participants who are active and prominent as well as mid-scale businesses operating in this market were interviewed in-depth for this supply-side report by overall Global Market Research.
Extensive primary research was conducted to gain a deeper grasp of the market and industry. Both primary and secondary research, as well as years of pertinent professional experience, are used to support the analysis. By analyzing past and present market patterns, our experts were able to forecast the market's course over the following seven years. For the geographically offered categories in the list of market tables, it differs per category. In connection with the Global Market research report, we also conducted a number of primary interviews with senior level executives (VP, CEO's, Directors, Marketing Directors, Business Development Managers, CFOs, Technical Consultants, Key Opinion Leaders, Industry Experts, Decision Matrix Authorities, and other crucial individuals) of the key industry players who dominated the Global market.
The primary purpose of secondary research was to gather, identify, and validate the information necessary for the thorough, technical, market-focused, and commercial analysis of the global market. With the use of this study, it was also possible to classify and segment the market in accordance with market trends, geographic markets, and regional considerations linked to market type. Analysts have gathered data in the Distribution Channel for the study of the market from reliable sources including annual reports, journals, white papers, corporate presentations, company websites, international organizations of Energy and Power manufacturers, credible paid databases, and many others to gather reliable intel.
Both top-down and bottom-up methodologies were employed to assess the accuracy of the global market size. The market for as a whole was estimated using these methods for a number of different dependent submarkets. Secondary research was used to address the major industry players, and primary and secondary research was used to calculate their market shares in the various regions. This complete intellectual process includes reading the annual and financial reports of the top market participants and conducting in-depth interviews with top industry executives (VP, CEO, Marketing Directors, and Business Development Managers) to gain important industry insights.
Through reliable secondary sources and validated primary sources, the classification of the global markets and their geographic percentage splits were established. To obtain the final qualitative and quantitative data, all relevant variables that might have an impact on the market under investigation have been taken into consideration, inspected in great depth, verified through primary research, and assessed. This information was collected, added to, and thoroughly examined by professional analysts before being provided in this report. The process used to estimate the overall market size for this study is depicted in the following image as an example.
Report Code :
RL65504
Published on :
Upcoming
Request a Free Sample Report
Speak to Analyst